GLP1R and type 2 diabetes mellitus: The results of this study support the hypothesis that SGLT2i and GLP1-ra may have a beneficial role in preventing the development of DMO in individuals with type 2 diabetes taking insulin, but due to the study design they do not establish a causal link.